Annual profit of Recipharm 2009-2020
In 2017, Swedish pharmaceutical company Recipharm made its largest loss during the observed period from 2009 to 2020, with some 160 million Swedish kroner. However, annual net profits increased significantly again the following years, and in 2019, the company made annual profits of 343 million Swedish kronor. Recipharm is a Swedish pharmaceutical contract development and manufacturing organization, founded in Stockholm in 1995.